The seven genes showing an expression ratio in melanoma/controls <0.5 or >2 were then identified, namely: SCNN1A, ANO1, GJB3, GABRE, KCNK7, GJB1, KCNN2 (see Table 3) and were considered second-round validated. This evidence concerns the gene GABRE and melanoma.